Skip to main content

Table 3 Acceptability between the five kinds of antipsychotic groups after 6–8 weeks of treatment (N, %)

From: The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial

Groups

N

Disc. of initially assigned APs

Use of concomitant APs

Maintaining initially assigned APs

Aripiprazole

39

16 (0.41)

8 (0.21)

15 (0.38)

Risperidone

43

20 (0.47)

3 (0.069)

20 (0.47)

Quetiapine

39

12 (0.31)

4 (0.10)

23 (0.59)a

Olanzapine

35

14 (0.4)

0

21 (0.60)a

Ziprasidone

19

12 (0.63)

2 (0.11)

5 (0.26)

  1. Values are represented as N: number of patients; APs: antipsychotics; Disc.: discontinuation
  2. aComparison of quetiapine and olanzapine with ziprasidone, both with P < 0.05
Back to article page

Annals of General Psychiatry

ISSN: 1744-859X